Global Alzheimer's Platform Foundation Revenue and Competitors
Estimated Revenue & Valuation
- Global Alzheimer's Platform Foundation's estimated annual revenue is currently $14.1M per year.
- Global Alzheimer's Platform Foundation's estimated revenue per employee is $243,000
Employee Data
- Global Alzheimer's Platform Foundation has 58 Employees.
- Global Alzheimer's Platform Foundation grew their employee count by 41% last year.
Global Alzheimer's Platform Foundation's People
Name | Title | Email/Phone |
---|---|---|
1 | Senior Director, Programs, Marketing & Communications | Reveal Email/Phone |
2 | Senior Director Operations, GPS Program | Reveal Email/Phone |
3 | Associate Director, Study Engagement | Reveal Email/Phone |
4 | Associate Director, Clinical Operations | Reveal Email/Phone |
5 | Senior Manager Recruitment and Clinical Trial Optimization | Reveal Email/Phone |
6 | Marketing Manager | Reveal Email/Phone |
7 | Senior Project Coordinator, Trial Recruitment and Study Solutions | Reveal Email/Phone |
Global Alzheimer's Platform Foundation Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.8M | 36 | 3% | N/A | N/A |
#2 | $177.5M | 526 | 5% | N/A | N/A |
#3 | $839.2M | 2220 | 6% | N/A | N/A |
#4 | $4.2M | 22 | 5% | N/A | N/A |
#5 | $678.1M | 1794 | 7% | N/A | N/A |
#6 | $34.8M | 129 | 5% | N/A | N/A |
#7 | $21.6M | 80 | 4% | N/A | N/A |
#8 | $13.9M | 57 | 24% | N/A | N/A |
#9 | $3.1M | 19 | 0% | N/A | N/A |
#10 | $5.1M | 27 | -4% | N/A | N/A |
What Is Global Alzheimer's Platform Foundation?
The GAP Foundation is joining together leading academic researchers, pharmaceutical companies, nonprofit organizations and foundations, and governments around the world to reduce the time, cost and risk of Alzheimer’s clinical trials in order to speed innovative medicines to those with or at risk of Alzheimer’s disease. The GAP Foundation is establishing a standing global trial-ready platform to drive quality, efficiency, and innovation in Alzheimer’s Clinical Trials, seeking to reduce clinical testing cycle times by two years or more and to achieve greater uniformity in trial populations. It is doing that by building large, well-characterized trial-ready cohorts, a network of certified high-performance clinical trial sites, and an adaptive proof-of-concept trial mechanism
keywords:N/AN/A
Total Funding
58
Number of Employees
$14.1M
Revenue (est)
41%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $15M | 58 | N/A | N/A |
#2 | $11M | 58 | -3% | N/A |
#3 | $9.4M | 58 | 23% | N/A |
#4 | $14.1M | 58 | -2% | N/A |
#5 | $13.1M | 58 | 12% | N/A |